Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
Cell Metabolism|March 31, 2015
Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathyGaia Cermenati, Matteo Audano, Silvia Giatti, et al.
Pharmacology Research & Perspectives|July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areataSamira Anderson, Guido Cavaletti, Linda J Hood, et al.
Frontiers in Pharmacology|February 7, 2022
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic PainPeter Bloomingdale, Cristina Meregalli, Kevin Pollard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational studyChristine Verboon, Thomas Harbo, David R Cornblath, et al.
Journal of Neuroinflammation|August 23, 2018
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in ratsCristina Meregalli, Ivan Marjanovic, Carla Scali, et al.
Experimental Neurology|November 17, 2016
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathyMarianna Monfrini, Elisabetta Donzelli, Virginia Rodriguez-Menendez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guidelineDawn L Hershman, Christina Lacchetti, Robert H Dworkin, et al.
European Journal of Pharmacology|October 1, 2018
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent modelsAlessia Chiorazzi, Krystyna M Wozniak, Rana Rais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2020
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline UpdateCharles L Loprinzi, Christina Lacchetti, Jonathan Bleeker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2016
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)Deirdre R Pachman, Rui Qin, Drew Seisler, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Cell Metabolism|March 31, 2015
Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathyGaia Cermenati, Matteo Audano, Silvia Giatti, et al.
Pharmacology Research & Perspectives|July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areataSamira Anderson, Guido Cavaletti, Linda J Hood, et al.
Frontiers in Pharmacology|February 7, 2022
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic PainPeter Bloomingdale, Cristina Meregalli, Kevin Pollard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 9, 2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational studyChristine Verboon, Thomas Harbo, David R Cornblath, et al.
Journal of Neuroinflammation|August 23, 2018
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in ratsCristina Meregalli, Ivan Marjanovic, Carla Scali, et al.
Experimental Neurology|November 17, 2016
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathyMarianna Monfrini, Elisabetta Donzelli, Virginia Rodriguez-Menendez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guidelineDawn L Hershman, Christina Lacchetti, Robert H Dworkin, et al.
European Journal of Pharmacology|October 1, 2018
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent modelsAlessia Chiorazzi, Krystyna M Wozniak, Rana Rais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2020
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline UpdateCharles L Loprinzi, Christina Lacchetti, Jonathan Bleeker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 19, 2016
Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)Deirdre R Pachman, Rui Qin, Drew Seisler, et al.
Pageof 27